Mirosław Janowski

Learn More
BACKGROUND AND PURPOSE A variety of approaches are employed for treatment of Chiari I malformation. They differ in extent of cranio-c ervical decompression. A technique based on arachnoid preservation and duroplasty was introduced in our department in 2001. The aim of the study is to compare between the previous and the present technique. MATERIAL AND(More)
Human umbilical cord blood (HUCB) is considered a promising source of neural progenitors capable of being used for cellular therapies in neurological disorders. Here we review briefly our work on the elucidation of mechanisms and development of practical standards as regards the selection, maintenance and use of cord blood derivatives for such purposes. Our(More)
Cerebrovascular diseases are the leading cause of severe disability worldwide, with an enormous financial burden for society. There is growing evidence that stem cell-based therapy may positively influence recovery from stroke. Cord blood is an attractive source of ontogenetically young, yet safe, stem cells. Conceptually, preclinical studies in which donor(More)
BACKGROUND AND PURPOSE A variety of methods have been employed for syrinx drainage, especially for treatment of syringomyelia unrelated to Chiari 1 malformation (C1M). Research on CSF circulation revealed that perpetual syrinx increase may result from disturbances of CSF flow and transient hypertension within the spinal subarachnoid space. Thus the concept(More)
  • 1